Skip to main content
Medicina logoLink to Medicina
. 2021 Jan 20;57(2):83. doi: 10.3390/medicina57020083

Transradial Embolization, an Underused Type of Uterine Artery Embolization Approach: A Systematic Review

Loredana Maria Himiniuc 1,2, Mara Murarasu 2, Bogdan Toma 1,2,*, Razvan Popovici 1, Ana-Maria Grigore 1, Ioana-Sadiye Scripcariu 1, Mihaela Oancea 3,*, Mihaela Grigore 1
Editor: Simone Ferrero
PMCID: PMC7909283  PMID: 33498309

Abstract

Background and Objectives: The most utilized approach for the embolization of uterine arteries is the transfemoral path. However, the transradial approach (TRA) has been gaining popularity among cardiologic interventions in the last years but only few studies have shown its applicability in uterine myoma treatment. The objective of this paper is to assess the feasibility, safety and efficacy of TRA when compared with the transbrachial, transulnar or transfemoral approach (TFA) for uterine arteries embolization (UAE). Materials and methods: A systematic review of the literature that analyzes the TRA for UAE it was carried out, in order to assess its safety and effectiveness. It was systematically searched the literature (Google Scholar, PubMed/MEDLINE, Cochrane Library and Embase) using the words “uterine artery embolization”/“uterine embolization” and “transradial”/“radial”. All the relevant papers published until March 2020 were retrieved and analyzed. Results: Ten studies were considered eligible for this topic. TRA is a comparable method with TFA for uterine artery embolization. Conclusions: These studies allowed us to conclude that TRA is as safe and efficient as TFA. Its advantages include few complications, shorter hospitalization period, and rapid mobilization but a steeper learning curve has the disadvantage of a longer learning curve compared to TFA. Yet, these findings are built on few reports and more research is needed.

Keywords: uterine artery embolization, transradial approach, transradial embolization, radial approach, myoma

1. Introduction

Uterine artery embolization (UAE) represents a feasible therapeutic option introduced in clinical practice for females with symptomatic uterine leiomyoma who want to avoid the surgical intervention [1,2]. One of the first attempts of uterine artery embolization, as described in the literature, was performed in 1976 on two patients who were suffering from intractable metrorrhagia and were poor candidates for surgery [3], but two decades later, in 1995, Ravina et al. reported successful outcomes of UAE in 16 cases of uterine myoma [4]. Since then, several large studies have proved both the effectiveness and the safety of UAE [5,6] and current guidelines on this topic, established the impact of UAE for fertile patients who desire a pregnancy, the clinical failure risk or re-intervention risk of this procedure, but also the success of the intervention based on clinical symptomatology. Hence, women with symptomatic fibroids, with contraindications for surgery due to an associate medical condition, or who does not accept blood transfusion or who had a previous failed surgery for multiple fibroids are fine candidates for UAE procedure [7]. In addition, although uterine myoma is still the main indication for UAE, other conditions such as obstetrical hemorrhage [8], adenomyosis [9], and cervical ectopic pregnancy [10] can benefit from it.

The classic and the most utilized approach for UAE is by transfemoral catheterization. The advantages of this access site are its easy location and approach for puncture and hemostasis. When TFA is difficult, the access through other vessels, including the brachial, radial, and ulnar arteries, is especially used in cardiologic interventions. The transradial approach (TRA) has been gaining popularity over the last three decades, and nowadays represents a valuable technique for cardiovascular interventions compared to TFA, due to its lower risk of complications such as hemorrhage and vascular complications (3.7% TFA vs. 1.4% TRA, p < 0.0001) [11,12]. Several studies proved the same efficacy as for the TFA in peripheral arterial procedures [13], showing great benefits for patient contentment, rapid hospital discharge due to short recovery time [14]. Nevertheless, the use of the radial artery access for non-coronary interventions, especially for UAE has received less attention and very few studies have been published on this topic. This paper represents a systematic review of the literature data in order to describe the use of TRA for UAE.

2. Materials and Methods

It was systematically searched for the relevant literature on PubMed/MEDLINE, Cochrane library, Google Scholar, Embase and grey literature (academic papers, including theses and dissertations, research and committee reports, government reports, conference papers), using the terms “uterine artery embolization”/“uterine embolization” and “transradial”/“radial” for all research papers that were published until March 2020. Two independent reviewers extracted data and assessed the quality of the articles. It was used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement, available by the Enhancing the Quality and Transparency of Health Research (EQUATOR) network, for all the analyses, study design, drafting, data interpretation and revision that were made.

The primary goal of this systematic review was to appreciate the procedure’s effectiveness and safety. It was considered successful when the entire embolization procedure was performed as intended, with no need to change the access route. Moreover, it was evaluated the complications that followed the local access of the catheter and their incidence rates.

3. Results

The literature search retrieved ten studies (eight retrospective and two prospective studies) [15,16,17,18,19,20,21,22,23,24], as further discussed below (Table 1). A conference proceeding abstract was also included between the studies [19].

Table 1.

Summary of studies that were included in the analysis.

Author, Year Type of Study Number of Cases and Indications Complications
Yamashita, 2007 Retrospective 7 UAE among 380 TRA non-coronary procedures Radial vasospasm (4 cases—1.1% of the total)
Radial artery injury (1 case)
 1.8% total complication rate
Resnick, 2014 Retrospective 29 UAE via TRA for symptomatic
uterine fibroids
No major or minor complications
No necessary to switch to TFA
Salmeron, 2015 Prospective 62 of 64 patients—bilateral UAE for uterine myoma Unilateral UAE (2 cases of 64)
No local vascular complications
Early readmission for pain 14%
Three patients (4.69%) went for
hysterectomy after UAE
Posham, 2016 Retrospective 116 UAE for uterine myoma among 1512 TRA non-coronary procedures Pseudo-aneurysm (1 case)
Seizure (1 case)
Hematoma/bleeding (13 cases)
Radial artery occlusion (11 cases)
Arm pain (6 cases)
Radial artery spasm (6 cases)
(for the whole series)
27 cases (1.8%) required TFA
Thakor, 2016 Retrospective 88 UAE for uterine myoma among 749 TRA non-coronary procedures No complications in the cases of UAE
Radial artery occlusion 0.3%
Small hematoma (1 case)
Biederman, 2016 Retrospective 4 UAE for uterine myoma among 22 TRA non-coronary procedures (18.2%) in morbidly obese patients No minor or major complications in
all 22 cases
Pham, 2016 Retrospective 60 cases UAE for uterine myoma
radial artery diameter 2–3 mm
(mean 2.4 mm)
Ecchymosis (1 case)
Radial artery spasm (1 case)
Mortensen, 2018 Prospective 39 TFA UAE vs. 27 TRA UAE for symptomatic fibroids +/− adenomyosis No necessary switch to TFA
No other complications
Gjoreski, 2019 Retrospective 11 UAE cases via TRA vs. 13 cases via TFA Non-flow-limiting dissection of left internal iliac artery in the TFA group
(1 case)
Prolonged pain in the left forearm in the TRA group (1 case)
Nakhaei, 2019 Retrospective 90 (91) UAE cases via TRA vs. 92 cases via TFA—1 case switched to TFA due to vasospasm (1%) Groin hematoma (5 cases) and groin pain (2 cases) in the TFA group
Transitory focal occlusion (4 cases) and focal pain (1 case) in the TRA group

UAE—Uterine artery embolization; TRA—Transradial approach; TFA—Transfemoral approach.

In all the studies except one, the Allen test or Barbeau test was performed before the procedures in order to verify the ulnar artery’s ability to counterbalance for transitory occlusion of the radial artery. Subjects with abnormal Allen or Barbeau test results were excluded from the study. Pre-procedural sonography assessment was reported in seven studies to measure the radial artery caliber, anatomical varieties, and for guided puncture.

The 4-French or 5-French diameter catheter with 100–150 cm length was mostly used with the addition of various micro-catheters in some cases where anatomy of the vessels was found abnormal and for difficult procedures. The hemostasis was achieved using various compression devices (Table 2).

Table 2.

Materials and methods used for TRA technique.

Author, Year Pre-Procedural
Assessment
Access Catheter or Equipment Hemostasis
Yamashita, 2007 Allen test
Radial pulse palpation
22-gauge needle,
17 cm length 4F arterial introducer sheath (Slit Super-Sheath; Medikit, Tokyo, Japan),
Seldinger technique
130–150 cm length 4F KI-6 catheter (Medikit) was used for selective angiography and interventions Manual compression for 5 min
An original designed compression tourniquet comprising an elastic bandage around a small gauze roll placed on the puncture site, and fixed by elastic tape (5 h)
Resnick, 2014 Barbeau test
Radial and ulnar artery
sonography
21-gauge, 2.5 cm echogenic-tip needle,
Ultrasound guidance,
0.021 inch tapered hydrophilic 4-F Glidesheath (Terumo, Somerset, NJ, USA)
120-cm, 4F angled tip hydrophilic-coated Glidecath (Terumo),
For difficult anatomy:
Renegade Hi-Flo (Boston Scientific, Natick, Massachusetts, USA) or Progreat (Terumo) micro-catheters
TR Band (Terumo Interventional Systems)
Salmeron, 2015 - 7-cm length 5F radial arterial introducer sheath 125 cm length 5F curve catheter extra-wide multipurpose,
150 cm 2.7F micro-catheter (Renegade, Bolton Scientific, EE. UU.)
TR Band (Terumo Interventional Systems)
Posham, 2016 Barbeau test 21-gauge echogenic-tip needle,
Ultrasound guidance,
10-cm length Glidesheath (Terumo Interventional Systems, Somerset, NJ, USA),
Seldinger technique
100–150 cm length 5F catheter,
130–150 cm standard length micro-catheters
TR Band (Terumo Interventional Systems)
Thakor, 2016 Barbeau test 21-gauge needle,
Ultrasound guidance,
Hydrophilic sheath (Glidesheath Slender, Terumo Medical Corporation, Somerset, NJ, USA; Prelude Ease, Merit Medical Systems, South Jordan, UT, USA),
Seldinger technique
150 cm length 4F catheter,
Shorter base micro-catheter up to 125 cm,
Short non-flushable hemostatic valve (i.e., FLO30, Merit Medical Systems)
Compression device (i.e., Safeguard Radial, Merit Medical Systems)
-TR Band (Terumo Interventional Systems)
-R-Band (Vascular Solutions, Minneapolis, MN, USA)
Biederman, 2016 Barbeau test 21-gauge, 1.5″ (38 mm) echogenic tip needle (Teurmo, Somerset, NJ, USA),
Ultrasound-guided puncture,
Hydrophilic coated Glidesheath (Terumo)
0.021 nitinol guide wire (Terumo) TR Band (Terumo Interventional Systems)
Pham, 2016 Barbeau test
Radial artery diameter of 2.0–3.0 mm assessed by
ultrasonography
Ultrasound guidance,
4F Glidesheath (Terumo Medical Corporation, Somerset, NJ, USA)
- -
Mortensen, 2018 Barbeau test
Ultrasound assessment of radial artery caliber and anatomical variants
21G or 18G needle,
Ultrasound guidance,
11 cm 5F hydrophilic sheath (Prelude Ease, Merit Medical, South Jordan, UT, USA) placed over the guidance wire,
Seldinger technique
- Hemostasis technique with a Statseal hemostatic pad (Biolife, Sarasota, FL, USA) and a Safeguard radial hemostasis balloon (Merit Medical, South Jordan, UT, USA)
Gjoreski, 2019 Barbeau test
Radial arteries diameter assessment by ultrasonography (>2.5 mm)
Micropuncture set for transradial access (5F Slender Glidesheath, Terumo, Japan) 110 cm MP or 125 angled catheters for cannulation,
150 cm long 2.8F microcatheter (Program, Terumo, Japan) in combination with GT microwire was chosen for uterine artery super selective catheterization,
TR Band (Terumo Interventional Systems)
Nakhaei, 2019 Barbeau test or
modified Allen test
5F hydrophilic sheath (Prelude Ease, Merit Medical, South Jordan, UT, USA),
Seldinger technique
5F angled catheter (Berenstein Performa catheter, 125 cm, Merit Medical, or Vertebral catheter, 125 cm, Cook Medical, Bloomington, Indiana) and J-tip Glidewire (Terumo, Somerset, NJ, USA).
Maestro 150-cm microcatheter (Merit Medical) and microwire (Transcend 160 cm, Stryker Neurovascular, Fremont, CA, USA; or Fathom, 180 cm, Boston Scientific, Marlborough, MA, USA) were used to cannulate the horizontal component of the uterine artery
TR Band (Terumo Interventional Systems)

TRA—Transradial approach.

The success rate of UAE using TRA was very good among the selected studies, ranging from 95% to 100%, with an average of 98.86% as it is seen in Table 3. This is similar to TRA for cardiologic interventions, where the failure of the technique is limited (5% to 7% of cases) and is usually associated with elderly patients, women, and patients with a decreased body mass index. This increased success rate of the procedures using TRA might be because patients with uterine myoma are usually younger with no comorbidities. There was no permanent occlusion of the radial vessel reported among patients; instead, some cases of transitory radial occlusion were reported (Table 1).

Table 3.

Summary of TRA cases and technical success rate in patients with uterine fibroids.

Author, Year Technical Success of TRA (%) Number of UAEs Cases via TRA
Yamashita, 2007 95% of total 380 cases 7
Resnick, 2014 100 29
Salmeron, 2015 97 62
Posham, 2016 98.20 116
Thakor, 2016 99.50 88
Biederman, 2016 100 4
Pham, 2016 100 60
Mortensen, 2018 100 27
Gjoreski, 2019 100 11
Nakhaei, 2019 98.90 90
Total - 494

TRA—Transradial approach; UAE—Uterine artery embolization.

4. Discussion

Campeau firstly described transradial access for angiographic diagnosis in 1989 in a series of 100 patients [25]. He concluded that TRA is as effective and safe as the transbrachial approach, which was the alternative to the TFA at that time. The embolization method has been used in various hemorrhagic conditions such as rectus sheath hematoma or postpartum hemorrhage [26]. Nowadays, in many centers, TRA is the main access for both coronary angiography procedures and patients who go for cardiac interventions.

Several advantages have been attributed to TRA technique. The radial artery, compared to femoral artery or even ulnar artery, is shallow and easy to compress and bleeding is rapidly controlled. Because there are no major vessels or nerves on the radial artery topography, the risk for vascular and peripheral nerve injury is reduced and complications like compartment syndrome of the arm or arteriovenous fistulas have a low incidence [27]. The estimated incidence of vascular complications varies from 1.5% to 30.5% among transradial coronary procedures [28].

The RIVAL trial, the largest randomized multicenter comparison between TRA and TFA among acute coronary syndrome patients, demonstrated that while these two approaches had similar overall safety and efficacy, the TRA for coronary angiography and percutaneous coronary interventions significantly reduced major vascular complications by decreasing the incidence of large hematoma and pseudoaneurysms requiring closure [29].

A Cochrane systematic review that compared transradial access with transfemoral access for both diagnostic and interventional methods in patients with coronary artery disease reported a decreased cardiac death rate and short-term NACE, and similarities regarding the rate of acute myocardial infarction (RR 0.91, 95% CI 0.81 to 1.02; 19,430 cases; 11 randomized controlled trials) [30].

Moreover, TRA may have a protective role in acute kidney injury development after coronary interventions. The incidence of chronic kidney disease is lower in the next 6 months after TRA procedures compared to TFA in percutaneous coronary interventions [31]. Kooiman et al. reported a significantly decreased risk of developing acute kidney injury after TRA when compared to TFA (odds ratio 0.74, 95% confidence interval 0.58 to 0.96) [32].

In a randomized clinical trial where TRA was compared to TFA among cardiac patients, Cooper et al. reported the following benefits of TRA procedure: the patient’s choice, an increased quality of life metrics, no requirement for immobilization or bladder catheterization, and reduced hospitalization costs [33].

Despite its various advantages, TRA is not used worldwide. Some highly experienced TFA operators are reluctant to retrain in TRA due to several challenges in transradial access. They include anatomical variations, small lumen, radial artery spasm, and radial artery occlusion.

Although it is known that TRA has an increased learning curve compared to TFA [34], no statistical significance was observed between the procedures’ fluoroscopic time [22], showing that like other various types of procedures that are based on the operator’s skills, TRA-operating skills refine as the experience of the operator increase [35].

Some authors suggested that patients who are shorter than 165 cm and 170 cm present an anatomically reduced size of the arterial lumen, making the access technique more exhausting and complex [18,36]. However, the present equipment increases the benefits of TRA procedure, making it suitable and successful for a heterogeneous population.

Gender-based differences in the diameter of the distal radial artery are well known. A higher rate of vascular complications and technical failure may appear in women due to the reduced diameter of the artery [37]. Although the radial artery presents the capacity to expand, its diameter is considerably reduced compared to the femoral and brachial vessels, having a lumen diameter mean smaller than 3 mm [38]. Still, Pham et al. reported a success rate of UAE via TRA of 100% in 60 women with radial artery diameter between 2 and 3 mm, reporting only one case of arterial vasospasm [19].

The smaller the radial artery caliber is, the higher the chances of artery spasm and local discomfort during the intervention are. A reduced radial artery diameter represents a risk factor for the primary patency rate of arteriovenous fistulas. Yan et al. showed that in 65 patients who underwent transradial coronary interventions, TRA procedure decreases the response to flow-mediated dilatation and nitroglycerin-mediated dilatation, determining a rapid and persistent damage of the vasodilatation function [39].

Patients with palmar arch instability present a major incidence for vessel occlusion, and TRA is not indicated in this group category. For this reason, the subjective Allen’s test and objective tests like Barbeau test or Princeps Pollicis artery ultrasound are recommended for every patient before the procedure in order to evaluate the hand collateral patency [40].

The incidences of local vascular per procedural complications in UAE by TRA were low among the selected studies, ranging from 0 to 3.3%. The permanent occlusion of the radial vessel represents the most serious complication of TRA, with an incidence that varies in the literature from 1% to 10% [41], and this is probably because its occurrence is often clinically silent due to the dual blood supply of the hand. Moreover, the slender catheters and sheaths (4-French or 5-French) used for cardiology and gynecology interventions may contribute to the low incidence of radial artery permanent occlusion. In all ten studies, no such complication was described. Hydrophilic material was especially chosen for the radial approach in order to reduce the patient’s discomfort. The technique’s failure is mainly due to the difficult artery puncturing and secondly, to the anatomical vessel variations or arterial spasm. The administration of heparin, nitroglycerin and verapamil directly through the access sheath reduces the risk of arterial vasospasm and occlusion and this may be a fine reason for the higher success rate of the procedures.

Pain is an important issue to deal with during and after the procedure. Different associations of painkillers to manage pain were described in the selected studies. One of them reported a 14% readmission rate because of the pain (Table 1).

In Thakor’s study, 98% of individuals who previous opted for a femoral access intervention would desire the transradial route for following procedures. The main reasons for this preference are as follows: rehabilitation time after discharge, earlier ambulation after the intervention, seated or Semi-Fowler’s position sufficient for the post-interventional recovery, rapid hospital discharge, and embarrassment correlated to groin preparation [21]. It is also important to note that all patients who listed modesty as a reason for TRA were women, and this should be considered especially for the gynecological field.

In cases of non-coronary interventions, very few studies regarding TRA have been published. For UAE, ten articles were retrieved that describe this access site. In all studies, the indication for UAE was uterine myoma, except one in which adenomyosis was associated too [22].

Based on this literature review, both increased success rate and decreased incidence of local complications lead us to consider the transradial route as a valid option for UAE. Even if some professionals are reluctant to use this approach, mainly due to the longer learning curve, there are some clinical situations where an alternative route to classic TFA is mandatory. These relative contraindications represent cases such as important obesity, vascular complications during previous catheterizations via the femoral approach, known peripheral vascular conditions in the inferior limbs or difficulty in remaining supine for a long period [42]. In all these cases, the transradial access could be a valid way for performing the UAE, compared with radiofrequency myolysis or others [43].

The limitations of the analyzed studies are that they are (with two exceptions) retrospective studies and non-randomized. In the future, there is a need for prospective randomized studies performed by trained radiologists to evaluate the traditional TFA versus TRA route for UAE.

5. Conclusions

Uterine fibroid embolization using the TRA is as safe and as effective as the TFA. Its advantages include rapid mobilization and shorter hospital stay. However, it has a longer learning curve. This conclusion relies on a few studies and subsequent reports are required.

Acknowledgments

We thank the anonymous referees for their useful suggestions.

Author Contributions

Conceptualization, M.G. and L.M.H.; methodology, R.P. and M.O.; software, B.T. and A.-M.G.; validation, M.G., L.M.H. and I.-S.S.; formal analysis, M.O.; investigation, B.T.; resources, A.-M.G. and M.M.; writing—original draft preparation, M.G.; writing—review and editing, L.M.H. and B.T.; visualization, M.M. and R.P.; supervision, M.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Worthinghton-Kirsch R., Spies J.B., Myers E.R., Mulgund J., Mauro M., Pron G., Peterson E.D., Goodwin S., FIBROID Inverstigators The fibroid registry for outcomes data (FIBROID) for uterine embolization: Short-term outcomes. Obstet. Gynecol. 2005;106:52–59. doi: 10.1097/01.AOG.0000165828.68787.a9. [DOI] [PubMed] [Google Scholar]
  • 2.Mara M., Maskova J., Fucikova Z., Kuzel D., Belsan T., Sosna O. Midterm clinical controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc. Intervent. Radiol. 2008;31:73–85. doi: 10.1007/s00270-007-9195-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Spies J.S., Pelage J.P. Uterine Artery Embolization and Gynecologic Embolotherapy. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2005. pp. 3–18. [Google Scholar]
  • 4.Ravina J.H., Herbreteau D., Ciraru-Vigneron N., Bouret J.M., Houdart E., Ayamard A., Merland J.J. Arterial embolization to treat uterine myomata. Lancet. 1995;346:671–672. doi: 10.1016/S0140-6736(95)92282-2. [DOI] [PubMed] [Google Scholar]
  • 5.Tropeano G., di Stasi C., Amoroso S., Vizzielli G., Masclilini F., Scambia G. Incidence and risk factors for clinical failure of uterine leiomyoma embolization. Obstet. Gynecol. 2012;120:269–276. doi: 10.1097/AOG.0b013e31825cb88e. [DOI] [PubMed] [Google Scholar]
  • 6.Dutton S., Hirst A., McPherson K., Nicholson T., Maresh M. A UK multicenter retrospective cohort study comparing hysterectomy and uterine artery embolization for the treatment of symptomatic uterine fibroids (HOPEFUL Study): Main results on medium-term safety and efficacy. BJOG. 2007;114:1340–1350. doi: 10.1111/j.1471-0528.2007.01526.x. [DOI] [PubMed] [Google Scholar]
  • 7.RCOG Clinical Recommendations on the Use of Uterine Artery Embolization (UAE) in the Management of Fibroids. [(accessed on 5 July 2020)];2013 Available online: https://www.rcog.org.uk/globalassets/documents/guidelines/23-12-2013_rcog_rcr_uae.pdf.
  • 8.Aoki M., Tokue H., Miyazaki M., Shibuya K., Hirasawa S., Oshima K. Primary postpartum hemorrhage: Outcome of uterine artery embolization. Br. J. Radiol. 2018;91:20180132. doi: 10.1259/bjr.20180132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liang E., Brown B., Rachinsky M. A clinical audit on the efficacy and safety of uterine artery embolization for symptomatic adenomyosis: Results in 117 women. Aust. N. Z. J. Obstet. Gynaecol. 2018;58:454–459. doi: 10.1111/ajo.12767. [DOI] [PubMed] [Google Scholar]
  • 10.Headley A. Management of cervical ectopic pregnancy with uterine artery embolization: A case report. J. Reprod. Med. 2014;59:425–428. [PubMed] [Google Scholar]
  • 11.Schirf B.E., Volgelzang R.L., Chrisman H.B. Complications of uterine fibroid. Semin. Intervent. Radiol. 2006;23:143–149. doi: 10.1055/s-2006-941444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Feldman D.N., Swaminathan R.V., Kaltenbach L.N., Baklanov D.V., Kim L.K., Wong S.C., Minutello R.M., Messenger J.C., Moussa I., Garratt K.N., et al. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention an updated report from the national cardiovascular data registry (2007−2012) Circulation. 2003;127:2295–2306. doi: 10.1161/CIRCULATIONAHA.112.000536. [DOI] [PubMed] [Google Scholar]
  • 13.Oren O., Oren M., Turgeman Y. Transradial versus transfemoral in peripheral arterial interventions. Int. J. Angiol. 2016;25:148–152. doi: 10.1055/s-0035-1563607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bishay V.L., Biederman D.M., Ward T.J., van der Bom I.M., Patel R.S., Kim E., Nowakowski F.S., Lookstein R.A., Fischman A.M. Transradial approach for hepatic radioembolization: Initial results and technique. AJR Am. J. Roentgenol. 2016;207:1112–1121. doi: 10.2214/AJR.15.15615. [DOI] [PubMed] [Google Scholar]
  • 15.Yamashita T., Imai S., Tamada T., Yamamoto A., Egashira N., Watanabe S., Higashi H., Gyoten M. Transradial approach for noncoronary angiography and interventions. Catheter. Cardiovasc. Interv. 2007;70:303–308. doi: 10.1002/ccd.21169. [DOI] [PubMed] [Google Scholar]
  • 16.Resnick N.J., Kim E., Patel R.S., Lookstein R.A., Nowakowski F.S., Fischman A.M. Uterine artery embolization using a transradial approach: Initial experience and technique. J. Vasc. Interv. Radiol. 2014;25:443–447. doi: 10.1016/j.jvir.2013.11.010. [DOI] [PubMed] [Google Scholar]
  • 17.Ruiz Salmeron R., Caraballo A.J., Ramila C.J., Vidal Martin J.M., Capparrros C., Micelli A. Embolizacio’n de los miomas uterinos por vıa transradial. Prog. Obstet. Gineco. 2016;59:211–217. [Google Scholar]
  • 18.Posham R., Biederman D.M., Patel R.S., Kim E., Tabori N.E., Nowakowski F.S., Lookstein R.A., Fischman A.M. Transradial Approach for Noncoronary Interventions: A Single-Center Review of Safety and Feasibility in the First 1500 Cases. J. Reprod. Interv. Radiol. 2016;27:159–166. doi: 10.1016/j.jvir.2015.10.026. [DOI] [PubMed] [Google Scholar]
  • 19.Pham S., Arampulikan J., Ruiz D., Resnick N. Safety and efficacy of transradial uterine fibroid embolization via small caliber arterial access. J. Vasc. Interv. Radiol. 2016;27:S21. doi: 10.1016/j.jvir.2015.12.067. [DOI] [Google Scholar]
  • 20.Biederman D.M., Marinelli B., O’Connor P.J., Titano J.J., Patel R.S., Kim E., Tabori N.E., Nowakowski F.S., Lookstei R.A., Fischman A.M. Transradial access for visceral endovascular interventions in morbidly obese patients: Safety and feasibility. J. Vasc. Access. 2016;17:256–260. doi: 10.5301/jva.5000530. [DOI] [PubMed] [Google Scholar]
  • 21.Thakor A.S., Alshammari M.T., Liu D.M., Chung J., Ho S.G.F., Legiehn G.M., Machan L., Fischman A.M., Patel R.S., Klass D. Transradial Access for Interventional Radiology: Single-Centre Procedural and Clinical Outcome Analysis. Can. Assoc. Radiol. J. 2017;68:318–327. doi: 10.1016/j.carj.2016.09.003. [DOI] [PubMed] [Google Scholar]
  • 22.Mortensen C., Chung J., Liu D., Ho S., Legiehn G., Machan L., Klass D. Prospective study on total fluoroscopic time in patients undergoing uterine artery embolization: Comparing transradial and transfemoral approach. Cardiovasc. Intervent. Radiol. 2019;42:441–447. doi: 10.1007/s00270-018-2100-3. [DOI] [PubMed] [Google Scholar]
  • 23.Gjoreski A., Gjoreski J., Nancheva A. Uterine fibroid embolization via transradial versus transfemoral arterial access: Technical results. Open Access Maced. J. Med. Sci. 2019;7:579–582. doi: 10.3889/oamjms.2019.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nakhaei M., Mojtahedi A., Faintuch A., Sarwar A., Brook O.R. Transradial and transfemoral uterine fibroid embolization comparative study: Technical and clinical outcomes. J. Vasc. Interv. Radiol. 2020;31:123–129. doi: 10.1016/j.jvir.2019.08.016. [DOI] [PubMed] [Google Scholar]
  • 25.Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc. Diagn. 1989;16:3–7. doi: 10.1002/ccd.1810160103. [DOI] [PubMed] [Google Scholar]
  • 26.Gradauskas A., Venclauskas L., Pazusis M., Karpavicius A., Maleckas A. Comparison of the different treatment strategies for patients with rectus sheath haematma. Medicina. 2018;54:38. doi: 10.3390/medicina54030038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tizon-Marcos H., Barbeau G.R. Incidence of compartment syndrome of the arm in a large series of transradial approach for coronary procedures. J. Interv. Cardiol. 2008;21:380–384. doi: 10.1111/j.1540-8183.2008.00361.x. [DOI] [PubMed] [Google Scholar]
  • 28.Garg N., Madan B.K., Khanna R., Sinha A., Kapoor A., Tewari S., Kumar S., Goel P.K. Incidence and predictors of radial artery occlusion after transradial coronary angioplasty: Doppler-guided follow-up study. J. Invasive Cardiol. 2015;27:106–112. [PubMed] [Google Scholar]
  • 29.Jolly S.S., Yusuf S., Cairns J., Niemelä K., Xavier D., Widimsky P., Budaj A., Niemelä M., Valentin V., Lewis B.S., et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomised, parallel group, multicenter trial. Lancet. 2011;377:1409–1420. doi: 10.1016/S0140-6736(11)60404-2. [DOI] [PubMed] [Google Scholar]
  • 30.Kolkailah A.A., Alreshq R.S., Muhammed A.M., Zahran M.E., Anas El-Wegoud M., Nabhan A.F. Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease. Cochrane Database Syst. Rev. 2018;4:CD012318. doi: 10.1002/14651858.CD012318.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Vuurmans T., Byrne J., Fretz E., Janssen C., Hilton J.D., Klinke W.P., Djurdjev O., Levin A. Chronic kidney injury in patients after cardiac catheterization or percutaneous coronary intervention: A comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries. Heart. 2010;96:1538–1542. doi: 10.1136/hrt.2009.192294. [DOI] [PubMed] [Google Scholar]
  • 32.Kooiman J., Seth M., Dixon S., Wohns D., LaLonde T., Rao S.V., Gurm H.S. Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ. Cardiovasc. Interv. 2014;7:190–198. doi: 10.1161/CIRCINTERVENTIONS.113.000778. [DOI] [PubMed] [Google Scholar]
  • 33.Cooper C.J., El-Shiekh R.A., Cohen D.J., Blaesing L., Burket M.W., Basu A., Moore J.A. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am. Heart J. 1999;138:430–436. doi: 10.1016/S0002-8703(99)70143-2. [DOI] [PubMed] [Google Scholar]
  • 34.Salgado Fernandez J., Calvino Santos R., Vazquez Rodriguez J.M., Vázquez González N., Vázquez Rey E., Pérez Fernández R., Bouzas Zubeldía B., Castro Beiras A. Transradial Approach to coronary angiography and angioplasty: Initial experience and learning curve. Rev. Esp. Cardiol. 2003;56:152–159. doi: 10.1016/s0300-8932(03)76839-0. [DOI] [PubMed] [Google Scholar]
  • 35.Das R., Lucatelli P., Wang H., Belli A.M. Identifying the learning curve for uterine artery embolization in an interventional radiological training unit. Cardiovasc. Intervent. Radiol. 2015;38:871–877. doi: 10.1007/s00270-014-1040-9. [DOI] [PubMed] [Google Scholar]
  • 36.Dehghani P., Mohammad A., Bajaj R., Hong T., Suen C.M., Sharieff W., Chisholm R.J., Kutryk M.J., Fam N.P., Cheema A.N. Mechanism and predictors of failed transradial approach for percutaneous coronary interventions. JACC Cardiovasc. Interv. 2009;2:1057–1064. doi: 10.1016/j.jcin.2009.07.014. [DOI] [PubMed] [Google Scholar]
  • 37.Kim Y., Ahn Y., Kim M.C., Sim D.S., Hong Y.J., Kim J.H., Jeong M.H. Gender differences in the distal radial artery diameter for the snuffbox approach. Cardiol. J. 2018;25:639–641. doi: 10.5603/CJ.2018.0128. [DOI] [PubMed] [Google Scholar]
  • 38.Norimatsu K., Kusumoto T., Yoshimoto K., Tsukamoto M., Kuwano T., Nishikawa H., Matsumura T., Miura S.I. Importance of measurement of the diameter of the distal radial artery in a distal radial approach from the anatomical snuffbox before coronary catheterization. Heart Vessel. 2019;34:1615–1620. doi: 10.1007/s00380-019-01404-2. [DOI] [PubMed] [Google Scholar]
  • 39.Yan Z., Zhou Y., Zhao Y., Zhou Z., Yang S., Wang Z. Impact of transradial coronary procedures on radial artery function. Angiology. 2014;65:104–107. doi: 10.1177/0003319713479650. [DOI] [PubMed] [Google Scholar]
  • 40.Kiang S.C., Nasiri A.J., Strilaeff R.R., Prasad V.S., Bharadwaj A.S., Miller P.A., Abou-Zamzam A.M., Jr., Tomihama R.T. Analysis of subjective and objective screening techniques as predictors of safety for radial artery intervention. Ann. Vasc. Surg. 2020;65:33–39. doi: 10.1016/j.avsg.2019.11.011. [DOI] [PubMed] [Google Scholar]
  • 41.Kotowycz M.A., Dzavik V. Radial artery patency after transradial catheterization. Circ. Cardiovasc. Interv. 2012;5:127–133. doi: 10.1161/CIRCINTERVENTIONS.111.965871. [DOI] [PubMed] [Google Scholar]
  • 42.Corrales J. Radial artery access: Should it be used more often? Rev. Esp. Cardiol. 2003;56:124–127. doi: 10.1016/s0300-8932(03)76835-3. [DOI] [PubMed] [Google Scholar]
  • 43.Fasciani A., Turtulici G., Siri G., Ferrero S., Sirito R. A prospective intervention trial on tailored radiofrequency ablation of uterine myomas. Medicina. 2020;56:122. doi: 10.3390/medicina56030122. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicina are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES